Test Bank:
y6
Advanced Pharmacology for Prescribers 1st Edition Luu Kayingo Latest
y6 y6 y6 y6 y6 y6 y6 y6 y
6 Edition, 2024
y6
, Table of Contents y6 y6
Chapter 1: An Introduction to Evidence-Based Clinical Practice Guidelines ......................................... 3
y6 y6 y6 y6 y6 y6 y6 y6
Chapter 2: Pharmacokinetics /Chapter3: Pharmacodynamics .................................................................. 13
y6 y6 y6 y6
Chapter4: Pharmacogenetics and Pharmacogenomics............................................................................... 25
y6 y6 y6
Chapter 5: Pharmacology Across the Life Span ...................................................................................... 30
y6 y6 y6 y6 y6 y6
Chapter 6: Drug-Therapy Prescribing in Special Populations ................................................................. 36
y6 y6 y6 y6 y6 y6
Chapter 7: Drug Development and Approval........................................................................................... 45
y6 y6 y6 y6 y6
Chapter 8-Chapter 10: Foundations of Prescription Writing Chapter 9: ResponsibleControlled-
y6 y6 y6 y6 y6 y6 y6 y6 y6
Substance Prescribing Chapter 10: Antibiotic Stewardship ...................................................................... 51
y6 y6 y6 y6 y6
Chapter 11: Applied Calculations for Prescribing ................................................................................... 58
y6 y6 y6 y6 y6
Chapter 12-: Promoting Adherence With Pharmacotherapy II: System-Specific and Patient-
y6 y6 y6 y6 y6 y6 y6 y6 y6
Focused Prescribing Chapter 13: Pharmacotherapy for Ear, Nose, Mouth, andThroat Conditions /Chapt
y6 y6 y6 y6 y6 y6 y6 y6 y6 y6 y6
er 14: Pharmacotherapy for Eye Conditions.............................................................................................. 67
y6 y6 y6 y6 y6
Chapter 15: Pharmacotherapy for Skin Conditions.................................................................................. 74
y6 y6 y6 y6 y6
Chapter 16: Pharmacotherapy for Neurologic Conditions ....................................................................... 81
y6 y6 y6 y6 y6
Chapter 17: Pharmacotherapy for Cardiovascular Conditions ................................................................ 94
y6 y6 y6 y6 y6
Chapter 18: Pharmacotherapy for Respiratory Conditions .................................................................... 106
y6 y6 y6 y6 y6
Chapter 19: Pharmacotherapy for Gastrointestinal Conditions and Conditions RequiringNutritional Sup
y6 y6 y6 y6 y6 y6 y6 y6 y6
port............................................................................................................................................................. 117
Chapter 20: Pharmacotherapy for Genitourinary Conditions ................................................................ 128
y6 y6 y6 y6 y6
Chapter 21: Pharmacotherapy for Renal, Acid–Base, Fluid, and Electrolyte Disorders ..................... 133
y6 y6 y6 y6 y6 y6 y6 y6 y6
Chapter 22: Pharmacotherapy for Musculoskeletal and Rheumatologic Conditions........................... 146
y6 y6 y6 y6 y6 y6 y6
Chapter 23: Therapeutic Applications of Immunology and Vaccines ................................................. 158
y6 y6 y6 y6 y6 y6 y6
Chapter 24: Pharmacotherapy for Endocrine Disorders ........................................................................ 163
y6 y6 y6 y6 y6
Chapter 25: Pharmacotherapy for Hematologic Disorders .................................................................... 174
y6 y6 y6 y6 y6
Chapter 26: Hematology/Oncology and Supportive Care for the Nononcologist ................................ 190
y6 y6 y6 y6 y6 y6 y6 y6
Chapter 27: Pharmacotherapy Related to Women’s Health Conditions .............................................. 196
y6 y6 y6 y6 y6 y6 y6
Chapter 28: Pharmacotherapy Related to Men’s Health Conditions .................................................... 211
y6 y6 y6 y6 y6 y6 y6
Chapter 29: Pharmacotherapy Related to Transgender Care ................................................................ 217
y6 y6 y6 y6 y6 y6
Chapter 30: Antimicrobial Pharmacotherapy .......................................................................................... 224
y6 y6 y6
Chapter 31: Antiretroviral Pharmacotherapy........................................................................................... 235
y6 y6 y6
Chapter 32: Psychopharmacology and Integrative Health: Combined Treatment ofPsychiatric and Neur
y6 y6 y6 y6 y6 y6 y6 y6 y6 y6
ocognitive Conditions ................................................................................................................................ 247
y6
Chapter 33: Pharmacotherapy for Pain Management ............................................................................ 257
y6 y6 y6 y6 y6
Chapter 34: Substance Use Disorder III: Health Promotion and Maintenance.................................... 267
y6 y6 y6 y6 y6 y6 y6 y6 y6
Chapter 35: Over-the-Counter Medications ............................................................................................ 283
y6 y6 y6
Chapter 36: Pharmacotherapy for Obesity .............................................................................................. 291
y6 y6 y6 y6
,Chapter 1: An Introduction to Evidence-Based Clinical Practice Guidelines
y6 y6 y6 y6 y6 y6 y6 y6
MULTIPLE CHOICE y6
• What is the primary purpose of the nursing assessment?
y6 y6 y6 y6 y6 y6 y6 y6
A. Identifying underlying pathologic conditions y6 y6 y6
B. Assisting the physician in identifying medical conditions
y6 y6 y6 y6 y6 y6
C. Determining the patients mental status y6 y6 y6 y6
D. Exploring patient responses to health problems y6 y6 y6 y6 y6
ANS: D y6
A nursing assessment is done to identify the patients response to health
y6 y6 y6 y6 y6 y6 y6 y6 y6 y6 y6 y6
problems. During the nursing assessment phase, a comprehensive inform
y6 y6 y6 y6 y6 y6 y6 y6
ation base is developed through a physical examination, nursing history,
y6 y6 y6 y6 y6 y6 y6 y6 y6 y
medication history, and professional observation. Identifying underlying
6 y6 y6 y6 y6 y6 y6 y
pathologic conditions and assisting the physician in identifying medical
6 y6 y6 y6 y6 y6 y6 y6 y6 y6
conditions is not part of the nursing process. Determining the patients
y6 y6 y6 y6 y6 y6 y6 y6 y6 y6 y6
mental status is one part of the nursing assessment, but it is not the
y6 y6 y6 y6 y6 y6 y6 y6 y6 y6 y6 y6 y6 y
primary purpose.
6 y6
DIF: Cognitive Level: Comprehension
y6 y6 y6
REF: dm 36 OBJ: 1 | 3 TOP: Nursin
y6 y6 y6 y6 y6 y6 y6 y6 y6
g Process Step: Assessment
y6 y6 y6
MSC: NCLEX Client Needs Category: Health Promotion and Maintenance
y6 y6 y6 y6 y6 y6 y6 y6
• What is the basis of the NANDA I taxonomy?
y6 y6 y6 y6 y6 y6 y6 y 6
A. Functional health patterns y6 y6
B. Human response patterns y6 y6
C. Basic human needs y6 y6
D. Pathophysiologic needs y6
ANS: B y6
The NANDA I taxonomy identifies human response patterns. Fu
y 6 y 6 y 6 y 6 y 6 y 6 y 6 y6
nctional components of health patterns are limited to activity, fluid vol
y6 y6 y6 y6 y6 y6 y6 y6 y6 y6
ume, nutrition, self care, and sensory perception. Basic human needs c
y6 y6 y6 y6 y6 y6 y6 y6 y6 y6
omprise less than merely health patterns. Pathophysiologic needs are
y6 y6 y6 y6 y6 y6 y6 y6 y 6
not part of the scope of NANDA I.
y6 y6 y6 y6 y6 y6 y6
, DIF: Cognitive Level: Knowledge RE
y6 y6 y6 y6
F: pp. 37-38 OBJ: 5 TOP:
y6 y6 y6 y6 y6
Nursing Process Step: Diagnosis
y6 y6 y6
MSC: NCLEX Client Needs Category: Physiological Integrity
y6 y6 y6 y6 y6 y6
• Which task is included in the assessment step of the nursing process?
y6 y6 y6 y6 y6 y6 y6 y6 y6 y6 y6
A. Establishing patient goals/outcomes y6 y6
B. Implementing the nursing care plan (NCP) y6 y6 y6 y6 y6
C. Measuring goal/outcome achievement y6 y6
D. Collecting and communicating data y6 y6 y6
ANS: D y6
Data are collected and communicated in the assessment phase of the nur
y6 y6 y6 y6 y6 y6 y6 y6 y6 y6 y6
sing process. Establishing goals is the function of planning.
y6 y6 y6 y6 y6 y6 y6 y6
Implementing the NCP is the function of implementation. Measuring out
y6 y6 y6 y6 y6 y6 y6 y6 y6
come achievement is the function of evaluation.
y6 y6 y6 y6 y6 y6
DIF: Cognitive Level: Comprehensio
y6 y6 y6
n REF: dm 36 OBJ: 2 | 3 TOP: Nursi
y6 y6 y6 y6 y6 y6 y6 y6 y6
ng Process Step: Assessment
y6 y6 y6
MSC: NCLEX Client Needs Category: Health Promotion and Maintenance
y6 y6 y6 y6 y6 y6 y6 y6
• Which statement regarding nursing diagnoses is accurate?
y6 y6 y6 y6 y6 y6
a. Nursing diagnoses remain the same for as long as the disease is present.
y6 y6 y6 y6 y6 y6 y6 y6 y6 y6 y6 y6
b. Nursing diagnoses are written to identify disease states.
y6 y6 y6 y6 y6 y6 y6
c. Nursing diagnoses describe patient problems that nurses treat.
y6 y6 y6 y6 y6 y6 y6
d. Nursing diagnoses identify causes related to illness.
y6 y6 y6 y6 y6 y6
ANS: C y6
Diagnostic statements identify problems a nurse is independently able t
y6 y6 y6 y6 y6 y6 y6 y6 y6
o treat within the scope of professional practice. Nursing diagnoses var
y6 y6 y6 y6 y6 y6 y6 y6 y6 y6
y with the changing condition of the patient. The response patterns are
y6 y6 y6 y6 y6 y6 y6 y6 y6 y6 y6 y6
unique to the patient and are not disease specific. Nursing diagnoses de
y6 y6 y6 y6 y6 y6 y6 y6 y6 y6 y6
scribe the patients human response pattern.
y6 y6 y6 y6 y6
DIF: Cognitive Level: Comprehension
y6 y6 y6
y6
Advanced Pharmacology for Prescribers 1st Edition Luu Kayingo Latest
y6 y6 y6 y6 y6 y6 y6 y6 y
6 Edition, 2024
y6
, Table of Contents y6 y6
Chapter 1: An Introduction to Evidence-Based Clinical Practice Guidelines ......................................... 3
y6 y6 y6 y6 y6 y6 y6 y6
Chapter 2: Pharmacokinetics /Chapter3: Pharmacodynamics .................................................................. 13
y6 y6 y6 y6
Chapter4: Pharmacogenetics and Pharmacogenomics............................................................................... 25
y6 y6 y6
Chapter 5: Pharmacology Across the Life Span ...................................................................................... 30
y6 y6 y6 y6 y6 y6
Chapter 6: Drug-Therapy Prescribing in Special Populations ................................................................. 36
y6 y6 y6 y6 y6 y6
Chapter 7: Drug Development and Approval........................................................................................... 45
y6 y6 y6 y6 y6
Chapter 8-Chapter 10: Foundations of Prescription Writing Chapter 9: ResponsibleControlled-
y6 y6 y6 y6 y6 y6 y6 y6 y6
Substance Prescribing Chapter 10: Antibiotic Stewardship ...................................................................... 51
y6 y6 y6 y6 y6
Chapter 11: Applied Calculations for Prescribing ................................................................................... 58
y6 y6 y6 y6 y6
Chapter 12-: Promoting Adherence With Pharmacotherapy II: System-Specific and Patient-
y6 y6 y6 y6 y6 y6 y6 y6 y6
Focused Prescribing Chapter 13: Pharmacotherapy for Ear, Nose, Mouth, andThroat Conditions /Chapt
y6 y6 y6 y6 y6 y6 y6 y6 y6 y6 y6
er 14: Pharmacotherapy for Eye Conditions.............................................................................................. 67
y6 y6 y6 y6 y6
Chapter 15: Pharmacotherapy for Skin Conditions.................................................................................. 74
y6 y6 y6 y6 y6
Chapter 16: Pharmacotherapy for Neurologic Conditions ....................................................................... 81
y6 y6 y6 y6 y6
Chapter 17: Pharmacotherapy for Cardiovascular Conditions ................................................................ 94
y6 y6 y6 y6 y6
Chapter 18: Pharmacotherapy for Respiratory Conditions .................................................................... 106
y6 y6 y6 y6 y6
Chapter 19: Pharmacotherapy for Gastrointestinal Conditions and Conditions RequiringNutritional Sup
y6 y6 y6 y6 y6 y6 y6 y6 y6
port............................................................................................................................................................. 117
Chapter 20: Pharmacotherapy for Genitourinary Conditions ................................................................ 128
y6 y6 y6 y6 y6
Chapter 21: Pharmacotherapy for Renal, Acid–Base, Fluid, and Electrolyte Disorders ..................... 133
y6 y6 y6 y6 y6 y6 y6 y6 y6
Chapter 22: Pharmacotherapy for Musculoskeletal and Rheumatologic Conditions........................... 146
y6 y6 y6 y6 y6 y6 y6
Chapter 23: Therapeutic Applications of Immunology and Vaccines ................................................. 158
y6 y6 y6 y6 y6 y6 y6
Chapter 24: Pharmacotherapy for Endocrine Disorders ........................................................................ 163
y6 y6 y6 y6 y6
Chapter 25: Pharmacotherapy for Hematologic Disorders .................................................................... 174
y6 y6 y6 y6 y6
Chapter 26: Hematology/Oncology and Supportive Care for the Nononcologist ................................ 190
y6 y6 y6 y6 y6 y6 y6 y6
Chapter 27: Pharmacotherapy Related to Women’s Health Conditions .............................................. 196
y6 y6 y6 y6 y6 y6 y6
Chapter 28: Pharmacotherapy Related to Men’s Health Conditions .................................................... 211
y6 y6 y6 y6 y6 y6 y6
Chapter 29: Pharmacotherapy Related to Transgender Care ................................................................ 217
y6 y6 y6 y6 y6 y6
Chapter 30: Antimicrobial Pharmacotherapy .......................................................................................... 224
y6 y6 y6
Chapter 31: Antiretroviral Pharmacotherapy........................................................................................... 235
y6 y6 y6
Chapter 32: Psychopharmacology and Integrative Health: Combined Treatment ofPsychiatric and Neur
y6 y6 y6 y6 y6 y6 y6 y6 y6 y6
ocognitive Conditions ................................................................................................................................ 247
y6
Chapter 33: Pharmacotherapy for Pain Management ............................................................................ 257
y6 y6 y6 y6 y6
Chapter 34: Substance Use Disorder III: Health Promotion and Maintenance.................................... 267
y6 y6 y6 y6 y6 y6 y6 y6 y6
Chapter 35: Over-the-Counter Medications ............................................................................................ 283
y6 y6 y6
Chapter 36: Pharmacotherapy for Obesity .............................................................................................. 291
y6 y6 y6 y6
,Chapter 1: An Introduction to Evidence-Based Clinical Practice Guidelines
y6 y6 y6 y6 y6 y6 y6 y6
MULTIPLE CHOICE y6
• What is the primary purpose of the nursing assessment?
y6 y6 y6 y6 y6 y6 y6 y6
A. Identifying underlying pathologic conditions y6 y6 y6
B. Assisting the physician in identifying medical conditions
y6 y6 y6 y6 y6 y6
C. Determining the patients mental status y6 y6 y6 y6
D. Exploring patient responses to health problems y6 y6 y6 y6 y6
ANS: D y6
A nursing assessment is done to identify the patients response to health
y6 y6 y6 y6 y6 y6 y6 y6 y6 y6 y6 y6
problems. During the nursing assessment phase, a comprehensive inform
y6 y6 y6 y6 y6 y6 y6 y6
ation base is developed through a physical examination, nursing history,
y6 y6 y6 y6 y6 y6 y6 y6 y6 y
medication history, and professional observation. Identifying underlying
6 y6 y6 y6 y6 y6 y6 y
pathologic conditions and assisting the physician in identifying medical
6 y6 y6 y6 y6 y6 y6 y6 y6 y6
conditions is not part of the nursing process. Determining the patients
y6 y6 y6 y6 y6 y6 y6 y6 y6 y6 y6
mental status is one part of the nursing assessment, but it is not the
y6 y6 y6 y6 y6 y6 y6 y6 y6 y6 y6 y6 y6 y
primary purpose.
6 y6
DIF: Cognitive Level: Comprehension
y6 y6 y6
REF: dm 36 OBJ: 1 | 3 TOP: Nursin
y6 y6 y6 y6 y6 y6 y6 y6 y6
g Process Step: Assessment
y6 y6 y6
MSC: NCLEX Client Needs Category: Health Promotion and Maintenance
y6 y6 y6 y6 y6 y6 y6 y6
• What is the basis of the NANDA I taxonomy?
y6 y6 y6 y6 y6 y6 y6 y 6
A. Functional health patterns y6 y6
B. Human response patterns y6 y6
C. Basic human needs y6 y6
D. Pathophysiologic needs y6
ANS: B y6
The NANDA I taxonomy identifies human response patterns. Fu
y 6 y 6 y 6 y 6 y 6 y 6 y 6 y6
nctional components of health patterns are limited to activity, fluid vol
y6 y6 y6 y6 y6 y6 y6 y6 y6 y6
ume, nutrition, self care, and sensory perception. Basic human needs c
y6 y6 y6 y6 y6 y6 y6 y6 y6 y6
omprise less than merely health patterns. Pathophysiologic needs are
y6 y6 y6 y6 y6 y6 y6 y6 y 6
not part of the scope of NANDA I.
y6 y6 y6 y6 y6 y6 y6
, DIF: Cognitive Level: Knowledge RE
y6 y6 y6 y6
F: pp. 37-38 OBJ: 5 TOP:
y6 y6 y6 y6 y6
Nursing Process Step: Diagnosis
y6 y6 y6
MSC: NCLEX Client Needs Category: Physiological Integrity
y6 y6 y6 y6 y6 y6
• Which task is included in the assessment step of the nursing process?
y6 y6 y6 y6 y6 y6 y6 y6 y6 y6 y6
A. Establishing patient goals/outcomes y6 y6
B. Implementing the nursing care plan (NCP) y6 y6 y6 y6 y6
C. Measuring goal/outcome achievement y6 y6
D. Collecting and communicating data y6 y6 y6
ANS: D y6
Data are collected and communicated in the assessment phase of the nur
y6 y6 y6 y6 y6 y6 y6 y6 y6 y6 y6
sing process. Establishing goals is the function of planning.
y6 y6 y6 y6 y6 y6 y6 y6
Implementing the NCP is the function of implementation. Measuring out
y6 y6 y6 y6 y6 y6 y6 y6 y6
come achievement is the function of evaluation.
y6 y6 y6 y6 y6 y6
DIF: Cognitive Level: Comprehensio
y6 y6 y6
n REF: dm 36 OBJ: 2 | 3 TOP: Nursi
y6 y6 y6 y6 y6 y6 y6 y6 y6
ng Process Step: Assessment
y6 y6 y6
MSC: NCLEX Client Needs Category: Health Promotion and Maintenance
y6 y6 y6 y6 y6 y6 y6 y6
• Which statement regarding nursing diagnoses is accurate?
y6 y6 y6 y6 y6 y6
a. Nursing diagnoses remain the same for as long as the disease is present.
y6 y6 y6 y6 y6 y6 y6 y6 y6 y6 y6 y6
b. Nursing diagnoses are written to identify disease states.
y6 y6 y6 y6 y6 y6 y6
c. Nursing diagnoses describe patient problems that nurses treat.
y6 y6 y6 y6 y6 y6 y6
d. Nursing diagnoses identify causes related to illness.
y6 y6 y6 y6 y6 y6
ANS: C y6
Diagnostic statements identify problems a nurse is independently able t
y6 y6 y6 y6 y6 y6 y6 y6 y6
o treat within the scope of professional practice. Nursing diagnoses var
y6 y6 y6 y6 y6 y6 y6 y6 y6 y6
y with the changing condition of the patient. The response patterns are
y6 y6 y6 y6 y6 y6 y6 y6 y6 y6 y6 y6
unique to the patient and are not disease specific. Nursing diagnoses de
y6 y6 y6 y6 y6 y6 y6 y6 y6 y6 y6
scribe the patients human response pattern.
y6 y6 y6 y6 y6
DIF: Cognitive Level: Comprehension
y6 y6 y6
